167 results
PRE 14C
NMRD
Nemaura Medical Inc
19 Apr 24
Preliminary information
4:05pm
of the Reverse Split by our Board of Directors, there is no assurance that the price of our common stock would be, or remain, following the Reverse Split … . There can be no assurance that the Company will be able to comply with the listing requirements on a national stock exchange, including, but not limited
8-K
EX-99.1
0galuhf5j9p7osyre4d
3 Jan 24
Important Update on Listing Status and Strategic Direction
7:00am
8-K
EX-99.1
et6ogog1in1j
13 Dec 23
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
8:00am
8-K
EX-99.1
frtt37e86lisk
21 Nov 23
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
8:38am
8-K
EX-99.1
9ddvwf0s
14 Nov 23
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
12:00am
8-K
EX-99.1
8k8sosfjeyofysc
13 Nov 23
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
4:15pm
8-K
ifuwjcufl5 nj7
6 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
EX-99.1
lpb8fi
14 Sep 23
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
8:00am
8-K
EX-99.1
qpq4ho92say 5vy2
13 Sep 23
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
8:03am
424B8
c50858
11 Sep 23
Prospectus unintentially filed late
4:41pm
8-K
EX-99.1
nkfzxylx
11 Sep 23
Nemaura Medical Completes 100 Patient Study for sugarBEATÒ 24-hour Wear and Reports Interim Results
9:00am